ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor ModelsCherrie K. Donawho, David J. Frost, Velitchka Bontcheva-Diaz et al.|Clinical Cancer Research|2007Cited by 770
Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues: Synthesis, Structure−Activity Relationship, Pharmacokinetics, and In Vivo Antitumor Activity EvaluationLe Wang, Hing L. Sham, Keith W. Woods et al.|Journal of Medicinal Chemistry|2002Cited by 421
Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft ModelsAlex R. Shoemaker, Steven W. Elmore, Michael J. Mitten et al.|Clinical Cancer Research|2008Cited by 209